Cargando…

Diagnostic value of aquaporin-4-IgG live cell based assay in neuromyelitis optica spectrum disorders

OBJECTIVE: Determine the utility of aquaporin 4 IgG (AQP4-IgG) testing (live cell-based assay) for Neuromyelitis Optica Spectrum Disorders (NMOSD). METHODS: We included Mayo Clinic patients (1/1/2018-12/31/2019) tested for serum AQP4-IgG by live cell-based flow-cytometric assay. Medical records were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Redenbaugh, Vyanka, Montalvo, Mayra, Sechi, Elia, Buciuc, Marina, Fryer, James P., McKeon, Andrew, Lennon, Vanda A., Mills, John R., Weinshenker, Brian G., Wingerchuk, Dean M., Chen, John J., Tariq Bhatti, M., Lopez Chiriboga, A. Sebastian, Pittock, Sean J., Flanagan, Eoin P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637716/ https://www.ncbi.nlm.nih.gov/pubmed/34868626 http://dx.doi.org/10.1177/20552173211052656

Ejemplares similares

NMO-IgG: A Specific Biomarker for Neuromyelitis Optica
por: Weinshenker, Brian G., et al.
Publicado: (2006)

Aquaporin-4–binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2
por: Hinson, Shannon R., et al.
Publicado: (2008)

Spectrum of sublytic astrocytopathy in neuromyelitis optica
por: Guo, Yong, et al.
Publicado: (2021)

Positive Predictive Value of Myelin Oligodendrocyte Glycoprotein Autoantibody Testing
por: Sechi, Elia, et al.
Publicado: (2021)

Disruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorder
por: Asgari, Nasrin, et al.
Publicado: (2017)

Understanding the etiology and epidemiology of meningitis and encephalitis: now and into the future
por: Redenbaugh, Vyanka, et al.
Publicado: (2022)

Neuromyelitis optica pathogenesis and aquaporin 4
por: Graber, David J, et al.
Publicado: (2008)

Placebo-controlled study in neuromyelitis optica—Ethical and design considerations
por: Cree, Bruce AC, et al.
Publicado: (2015)

CNS Demyelinating Attacks Requiring Ventilatory Support With Myelin Oligodendrocyte Glycoprotein or Aquaporin-4 Antibodies
por: Zhao-Fleming, Hannah H., et al.
Publicado: (2021)

Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder
por: Wingerchuk, Dean M., et al.
Publicado: (2021)

Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide
por: Hor, Jyh Yung, et al.
Publicado: (2020)

Antibody to Aquaporin 4 in the Diagnosis of Neuromyelitis Optica
por: Paul, Friedemann, et al.
Publicado: (2007)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
por: Schanda, Kathrin, et al.
Publicado: (2015)

Cerebral Cortical Encephalitis in Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disease
por: Valencia‐Sanchez, Cristina, et al.
Publicado: (2022)

Pathogenic implications of cerebrospinal fluid barrier pathology in neuromyelitis optica
por: Guo, Yong, et al.
Publicado: (2017)

Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease
por: Dinoto, Alessandro, et al.
Publicado: (2022)

Clinical utility of testing AQP4-IgG in CSF: Guidance for physicians
por: Majed, Masoud, et al.
Publicado: (2016)

Anti-Aquaporin-1 Autoantibodies in Patients with Neuromyelitis Optica Spectrum Disorders
por: Tzartos, John S., et al.
Publicado: (2013)

A Response to: Letter to the Editor Regarding “Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder”
por: Wingerchuk, Dean M., et al.
Publicado: (2022)

Disability Outcomes in the N-MOmentum Trial of Inebilizumab in Neuromyelitis Optica Spectrum Disorder
por: Marignier, Romain, et al.
Publicado: (2021)

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica
por: Jarius, S., et al.
Publicado: (2008)

Patterns of Antibody Binding to Aquaporin-4 Isoforms in Neuromyelitis Optica
por: Mader, Simone, et al.
Publicado: (2010)

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
por: Wingerchuk, Dean M., et al.
Publicado: (2015)

Immunodominant T Cell Determinants of Aquaporin-4, the Autoantigen Associated with Neuromyelitis Optica
por: Nelson, Patricia A., et al.
Publicado: (2010)

Cerebrospinal Fluid Aquaporin-4 Antibody Levels in Neuromyelitis Optica Attacks
por: Sato, Douglas Kazutoshi, et al.
Publicado: (2014)

Convergence spasm due to aquaporin-positive neuromyelitis optica spectrum disorder
por: Özçelik, Pınar, et al.
Publicado: (2017)

Radiologically isolated aquaporin-4 antibody neuromyelitis optica spectrum disorder
por: Abdel-Mannan, Omar, et al.
Publicado: (2022)

A single relapse induces worsening of disability and health-related quality of life in patients with neuromyelitis optica spectrum disorder
por: Berthele, Achim, et al.
Publicado: (2023)

Attack adjudication in neuromyelitis optica spectrum disorder: Substantiation of criteria by magnetic resonance imaging and biomarkers in N-MOmentum
por: Weinshenker, Brian G, et al.
Publicado: (2023)

Autoimmune septin-5 cerebellar ataxia
por: Honorat, Josephe A., et al.
Publicado: (2018)

Challenges and opportunities in designing clinical trials for neuromyelitis optica
por: Weinshenker, Brian G., et al.
Publicado: (2015)

Detection of anti-aquaporin-4 autoantibodies in the sera of Chinese neuromyelitis optica patients★
por: Li, Miao, et al.
Publicado: (2013)

Fatal anti-aquaporin-4 seropositive neuromyelitis optica spectrum disorder in tuberculosis
por: Sridhar, Siddharth, et al.
Publicado: (2014)

Evaluation of Clinical Interest of Anti-Aquaporin-4 Autoantibody Followup in Neuromyelitis Optica
por: Chanson, Jean-Baptiste, et al.
Publicado: (2013)

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
por: Waters, Patrick, et al.
Publicado: (2016)

The single nucleotide polymorphism site of aquaporin-4 gene in patients with neuromyelitis optica
por: Wang, Qing-Song, et al.
Publicado: (2017)

Are aquaporin antibody titers useful outcome measures for neuromyelitis optica spectrum disorders?
por: Reindl, Markus
Publicado: (2020)

COVID-19 in a patient treated with eculizumab for aquaporin-4 neuromyelitis optica
por: Cabal-Herrera, Ana Maria, et al.
Publicado: (2021)

Female hormonal exposures and neuromyelitis optica symptom onset in a multicenter study
por: Bove, Riley, et al.
Publicado: (2017)

Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiology
por: Fujihara, Kazuo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jj8m6dhbk5a25sua3ugp9cn3hc